Atria Investments Inc reduced its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 7.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 131,965 shares of the company’s stock after selling 10,579 shares during the quarter. Atria Investments Inc’s holdings in Procter & Gamble were worth $18,912,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently modified their holdings of PG. Maseco LLP purchased a new position in shares of Procter & Gamble in the 4th quarter worth $28,000. Saranac Partners Ltd bought a new position in shares of Procter & Gamble during the 3rd quarter valued at approximately $30,000. Caitlin John LLC purchased a new position in shares of Procter & Gamble in the third quarter valued at about $34,000. Anfield Capital Management LLC lifted its position in shares of Procter & Gamble by 121.5% in the fourth quarter. Anfield Capital Management LLC now owns 237 shares of the company’s stock valued at $34,000 after acquiring an additional 130 shares in the last quarter. Finally, Legacy Wealth Managment LLC ID lifted its position in shares of Procter & Gamble by 162.6% in the fourth quarter. Legacy Wealth Managment LLC ID now owns 239 shares of the company’s stock valued at $34,000 after acquiring an additional 148 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on the stock. TD Cowen lifted their price target on shares of Procter & Gamble from $142.00 to $150.00 and gave the company a “hold” rating in a report on Monday, April 27th. The Goldman Sachs Group reduced their price objective on shares of Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 8th. UBS Group upped their price target on shares of Procter & Gamble from $166.00 to $172.00 and gave the stock a “buy” rating in a report on Monday, April 27th. Morgan Stanley cut their price target on shares of Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Finally, Barclays lowered their target price on Procter & Gamble from $155.00 to $146.00 and set an “equal weight” rating for the company in a report on Tuesday, April 14th. Eleven investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $161.06.
Insider Transactions at Procter & Gamble
In other news, CEO Ma. Fatima Francisco sold 5,549 shares of the stock in a transaction on Friday, February 27th. The shares were sold at an average price of $165.29, for a total value of $917,194.21. Following the sale, the chief executive officer owned 1,029 shares in the company, valued at $170,083.41. This represents a 84.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Moses Victor Javier Aguilar sold 15,169 shares of the stock in a transaction on Friday, February 13th. The stock was sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the completion of the sale, the insider owned 44,735 shares in the company, valued at $7,259,595.80. The trade was a 25.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 22,527 shares of company stock worth $3,667,283 over the last 90 days. 0.20% of the stock is currently owned by company insiders.
Procter & Gamble Price Performance
Shares of NYSE PG opened at $142.34 on Thursday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.53 and a current ratio of 0.73. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $170.99. The company has a market cap of $331.46 billion, a PE ratio of 20.81, a P/E/G ratio of 6.17 and a beta of 0.41. The business has a 50-day simple moving average of $146.77 and a two-hundred day simple moving average of $148.33.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.56 by $0.03. The company had revenue of $21.24 billion during the quarter, compared to analyst estimates of $21.52 billion. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.The firm’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the business posted $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 24th will be paid a $1.0885 dividend. The ex-dividend date is Friday, April 24th. This is an increase from Procter & Gamble’s previous quarterly dividend of $1.06. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.1%. Procter & Gamble’s dividend payout ratio (DPR) is currently 63.60%.
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Stories
- Five stocks we like better than Procter & Gamble
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
